Reata's Skyclarys got FDA approval in Feb 2023 and then received EU approval in Feb 2024, 12 months later.
- Forums
- ASX - By Stock
- NEU
- NEU is materially undervalued
NEU is materially undervalued, page-47
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.11 |
Change
0.410(3.23%) |
Mkt cap ! $1.675B |
Open | High | Low | Value | Volume |
$13.02 | $13.12 | $12.89 | $8.524M | 654.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 5580 | $13.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.11 | 11667 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 5580 | 13.040 |
1 | 1637 | 13.020 |
4 | 15028 | 13.000 |
1 | 39 | 12.990 |
1 | 2028 | 12.980 |
Price($) | Vol. | No. |
---|---|---|
13.120 | 3413 | 2 |
13.140 | 2028 | 1 |
13.150 | 139 | 3 |
13.160 | 2028 | 1 |
13.180 | 2028 | 1 |
Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online